ABBV vs SYK
By Alex · Tickerpine
AbbVie Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | SYK |
|---|---|---|
| Price | $295.03 | $309.64 |
| Market cap | $521.50B | $117.88B |
| P/E ratio | 50.7 | 33.0 |
| ROE | — | 16.02% |
| Profit margin | 15.67% | 13.78% |
| Revenue growth | 10.30% | 7.60% |
| Dividend yield | 2.35% | 1.14% |
| Beta | 0.19 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs SYK in plain English
- ABBV is the bigger company — about 4.4× the market cap of SYK.
- SYK is cheaper on earnings (P/E 33.0 vs 50.7).
- ABBV is growing revenue faster (10% vs 8%).
- ABBV has the higher dividend yield (2.35% vs 1.14%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.